Abstract
Major depressive disorder (MDD) is associated with increased volumes of visceral fat and a high prevalence of the metabolic syndrome. In turn, affective disorders are frequently found in patients with borderline personality disorder (BPD). It is therefore unclear whether BPD per se may influence body composition. In order to clarify a potential relationship between BPD and body composition, we measured visceral fat content (VFC) in young depressed women with and without comorbid BPD and related this parameter to various features of the metabolic syndrome. Visceral fat content was measured by magnetic resonance imaging in 22 premenopausal women with MDD only, in 44 women with comorbid MDD and BPD, in 12 female BPD patients without MDD, and in 34 healthy women (CG). Data showed that depressed women without comorbid BPD had a 335% higher VFC and women with comorbid BPD had a 250% higher VFC than the CG women. When controlling for age, data showed significant effects of MDD on VFC (F = 8.4; P = 0.005). However, BPD, with or without MDD, was not related to VFC. Young depressed women with and without comorbid BPD display increased visceral fat content when compared to control subjects and may therefore constitute a risk group for the development of the metabolic syndrome. BPD per se is not an additive risk factor in this context.
Similar content being viewed by others
References
Bertoni AG, Burke GL, Owusu JA, Carnethon MR, Vaidya D, Barr RG, Jenny NS, Ouyang P, Rotter JI (2010) Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 33(4):804–810
Bjorntorp P (2001) Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2:73–86
Chrousos GP (2000) The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 24 (Suppl 2):S50–S55
Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039–1049
Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I (1997) Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82:234–238
Dong M, Giles WH, Felitti VJ, Dube SR, Williams JE, Chapman DP, Anda RF (2004) Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation 110:1761–1766
Eich D, Neuhaus C, Gamma A, Angst J, Rossler W, Ajdacic-Gross V, Opravil M (2007) Is depression a risk factor for heart complaints? Longitudinal aspects in the Zurich study. Eur Arch Psychiatry Clin Neurosci 257:396–401
Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, Sebring N, Drinkard BE, Levy C, Reynolds JC, Csako G, Gold PW, Horne M, Cizza G (2005) Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism 54:918–924
Everson-Rose SA, Lewis TT, Karavolos K, Dugan SA, Wesley D, Powell LH (2009) Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med 71:410–416
Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS (1998) Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study. Am J Prev Med 14:245–258
Frankenburg FR, Zanarini MC (2004) The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 65:1660–1665
Frankenburg FR, Zanarini MC (2006) Obesity and obesity-related illnesses in borderline patients. J Personal Disord 20:71–80
Frankenburg FR, Zanarini MC (2006) Personality disorders and medical comorbidity. Curr Opin Psychiatry 19:428–431
Gladstone G, Parker G, Wilhelm K, Mitchell P, Austin MP (1999) Characteristics of depressed patients who report childhood sexual abuse. Am J Psychiatry 156:431–437
Gunderson JG, Stout RL, Sanislow CA, Shea MT, McGlashan TH, Zanarini MC, Daversa MT, Grilo CM, Yen S, Skodol AE (2008) New episodes and new onsets of major depression in borderline and other personality disorders. J Affect Disord 111:40–45
Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153:93–99
Inder WJ, Prickett TC, Mulder RT, Donald RA, Joyce PR (2001) Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology (Berl) 156:73–78
Kahl KG, Bester M, Greggersen W, Rudolf S, Dibbelt L, Stoeckelhuber BM, Gehl HB, Sipos V, Hohagen F, Schweiger U (2005) Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 67:407–412
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410
Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP (2004) Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66:316–322
Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49:837–845
Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, Visser M, Houston DK, Nicklas BJ, Tylavsky FA, Satterfield S, Goodpaster BH, Ferrucci L, Harris TB (2010) Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 18(12):2354–2361
Lee JM, Kim SR, Yoo SJ, Hong OK, Son HS, Chang SA (2009) The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res 37:1803–1812
Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF (2004) Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66:305–315
Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH (2009) Prevalence and correlates of undiagnosed depression among US adults with diabetes: the behavioral risk factor surveillance system, 2006. Diabetes Res Clin Pract 83(2):268–279
Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JC (2003) Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord 27:1267–1273
Lorenzo M, Fernandez-Veledo S, Vila-Bedmar R, Garcia-Guerra L, De Alvaro C, Nieto-Vazquez I (2008) Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci 86:E94–E104
Maes M (2010) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry (Epub ahead of print)
Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET (2002) Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry 63:126–134
Nichols GA, Hillier TA, Brown JB (2008) Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med 121:519–524
Odeleye OE, de Courten M, Pettitt DJ, Ravussin E (1997) Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46:1341–1345
Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C (2005) The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 183:308–315
Peters A, Pellerin L, Dallman MF, Oltmanns KM, Schweiger U, Born J, Fehm HL (2007) Causes of obesity: looking beyond the hypothalamus. Prog Neurobiol 81:61–88
Richter N, Juckel G, Assion HJ (2010) Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci 260(1):41–49
Ross R, Leger L, Morris D, de Guise J, Guardo R (1992) Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72:787–795
Rossi A, Marinangeli MG, Butti G, Scinto A, Di Cicco L, Kalyvoka A, Petruzzi C (2001) Personality disorders in bipolar and depressive disorders. J Affect Disord 65:3–8
Sansone RA, Wiederman MW, Sansone LA, Monteith D (2001) Obesity and borderline personality symptomatology: comparison of a psychiatric versus primary care sample. Int J Obes Relat Metab Disord 25:299–300
Schiavone P, Dorz S, Conforti D, Scarso C, Borgherini G (2004) Comorbidity of DSM-IV Personality Disorders in unipolar and bipolar affective disorders: a comparative study. Psychol Rep 95:121–128
Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ (1995) Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 38:797–802
Schweiger U, Greggersen W, Rudolf S, Pusch M, Menzel T, Winn S, Hassfurth J, Fassbinder E, Kahl KG, Oltmanns KM, Hohagen F, Peters A (2008) Disturbed glucose disposal in patients with major depression; application of the glucose clamp technique. Psychosom Med 70:170–176
Sigal RJ, El-Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH (1997) Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes 46:1025–1029
Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE (2006) Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 4:465–474
Stenholm S, Koster A, Alley DE, Visser M, Maggio M, Harris TB, Egan JM, Bandinelli S, Guralnik JM, Ferrucci L (2010) Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin Endocrinol (Oxf) 73(1):55–65
Sunnqvist C, Westrin A, Traskman-Bendz L (2008) Suicide attempters: biological stressmarkers and adverse life events. Eur Arch Psychiatry Clin Neurosci 258:456–462
Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG (1997) Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 41:1140–1142
Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454–1462
Trickett PK, Noll JG, Susman EJ, Shenk CE, Putnam FW (2010) Attenuation of cortisol across development for victims of sexual abuse. Dev Psychopathol (Winter) 22(1):165–175
Veilleux A, Rheaume C, Daris M, Luu-The V, Tchernof A (2009) Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women. J Clin Endocrinol Metab 94:3550–3557
Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, Yaffe K, Harris TB, Penninx BW (2010) Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 71(4):391–399
Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F, Heuser I (2002) Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64:274–277
Weber-Hamann B, Kopf D, Lederbogen F, Gilles M, Heuser I, Colla M, Deuschle M (2005) Activity of the hypothalamus-pituitary-adrenal system and oral glucose tolerance in depressed patients. Neuroendocrinology 81:200–204
Weber-Hamann B, Werner M, Hentschel F, Bindeballe N, Lederbogen F, Deuschle M, Heuser I (2006) Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 31:347–354
Yang K, Xie G, Zhang Z, Wang C, Li W, Zhou W, Tang Y (2007) Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust N Z J Psychiatry 41:266–273
Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V (1998) Axis I comorbidity of borderline personality disorder. Am J Psychiatry 155:1733–1739
Acknowledgments
This study was supported by a grant of the University of Luebeck (MUL 2301).
Conflict of interest
None of the authors reported potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greggersen, W., Rudolf, S., Fassbinder, E. et al. Major depression, borderline personality disorder, and visceral fat content in women. Eur Arch Psychiatry Clin Neurosci 261, 551–557 (2011). https://doi.org/10.1007/s00406-011-0194-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-011-0194-6